Advertisement
Advertisement
CRSP
CRISPR Therapeutics AG
51.31
USDSponsored
+1.35
+2.70%
Feb 02, 15:59 UTC -5
Closed
After-Market
51.24
-0.07
-0.13%
CRSP Earnings Reports
Positive Surprise Ratio
CRSP beat 20 of 37 last estimates.
54%
Next Report
Date of Next Report
Feb 17, 2026
Estimate for Q4 25 (Revenue/ EPS)
$4.33M
/-$1.17
Implied change from Q3 25 (Revenue/ EPS)
+386.67%
/--
Implied change from Q4 24 (Revenue/ EPS)
-87.88%
/+165.91%
CRISPR Therapeutics AG earnings per share and revenue
On Nov 10, 2025, CRSP reported earnings of -1.17 USD per share (EPS) for Q3 25, beating the estimate of -1.27 USD, resulting in a 8.57% surprise. Revenue reached 889.00 thousand, compared to an expected 9.08 million, with a -90.21% difference. The market reacted with a -0.98% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analysts forecast an EPS of -1.17 USD, with revenue projected to reach 4.33 million USD, implying an increase of 0.00% EPS, and increase of 386.67% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
What were CRISPR Therapeutics AG's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CRISPR Therapeutics AG reported EPS of -$1.17, beating estimates by 8.57%, and revenue of $889.00K, -90.21% below expectations.
How did the market react to CRISPR Therapeutics AG's Q3 2025 earnings?
The stock price moved down -0.98%, changed from $55.12 before the earnings release to $54.58 the day after.
When is CRISPR Therapeutics AG expected to report next?
The next earning report is scheduled for Feb 17, 2026.
What are the forecasts for CRISPR Therapeutics AG's next earnings report?
Based on 26
analysts, CRISPR Therapeutics AG is expected to report EPS of -$1.17 and revenue of $4.33M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement